Michael J. Dickinson, MBBS, DMedSci¹, Carmelo Carlo-Stella, MD², Franck Morschhauser, phd³, Emmanuel Bachy, MD, PhD⁴, Guillaume Cartron, MD, PhD^5*, Paolo Corradini, MD⁶, Nancy L. Bartlett, MD⁷, Gloria Iacoboni, MD^8*, Cyrus Khan^9*, Mark S. Hertzberg, MBBS¹⁰, Lorenzo Falchi, MD¹¹, Joshua Brody, MD^12*, Marek Trněný, MD, CSc¹³, Estefania Mulvihill^14*, Aurelien Berthier¹⁴, Alessia Bottos, PhD^14*, James Relf^15*, Fabiola Bene Tchaleu^16*, Linda Lundberg^14* and Martin Hutchings, MD, PhD¹⁷

¹Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, VIC, Australia
²Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
³Hôpital Claude Huriez and CHU de Lille, Lille, France
⁴Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁵CHU de Montpellier, Montpellier, France
⁶University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁷Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁸Vall d’Hebron University Hospital, Barcelona, Spain
⁹Allegheny Health Network, Pittsburgh, PA
¹⁰Prince of Wales Hospital and University of New South Wales, Sydney, Australia
¹¹Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Tisch Cancer Institute, New York, NY
¹³Charles University, Prague, Czech Republic
¹⁴F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁵Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁶Genentech, Inc., South San Francisco, CA
¹⁷Rigshospitalet, Copenhagen, Denmark

Matthew Matasar, MD, MS¹, Max S. Topp^2*, John N. Allan, MD³, Stephen M. Ansell, MD, PhD⁴, Jeffrey A. Barnes, MD, PhD^5*, Jon E. Arnason, MD⁶, Jean-Marie Michot^7*, Neta Goldschmidt^8*, Susan M. O'Brien⁹, Uri Abadi, MD^10,11*, Irit Avivi Mazza^12*, Jingxian Cai^13*, Julia Zecchini¹³, Min Zhu, PhD^13*, Jurriaan Brouwer-Visser¹³, Aafia Chaudhry¹³, Hesham Mohamed¹³, Srikanth Ambati¹³ and Jennifer L. Crombie, MD¹⁴

¹Division of Blood Disorders, Rutgers Cancer Institute and RWJBarnabas Health, New Brunswick, NJ
²Universitätsklinikum Würzburg, Würzburg, Germany
³Weill Cornell Medicine, New York, NY
⁴Mayo Clinic, Rochester, MN
⁵Massachusetts General Hospital Cancer Center, Boston, MA
⁶Beth Israel Deaconess Medical Center, Boston, MA
⁷Gustave Roussy Cancer Campus, Villejuif, France
⁸Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
⁹Chao Family Comprehensive Cancer Center, UC Irvine Medical Center, Orange, CA
¹⁰Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
¹¹Meir Medical Center, Kfar Saba, Israel
¹²Ichilov University Hospital, Tel-Aviv, Israel
¹³Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹⁴Dana-Farber Cancer Institute, Boston, MA

Franck Morschhauser, phd¹, David Belada, MD, PhD², Johannes Duell, MD^3*, Wojciech Jurczak, MD, PhD⁴, Tae Min Kim, MD, PhD^5*, Won Seog Kim, MD, PhD^6*, Takahiro Kumode, MD, PhD^7*, Javier López Jiménez, MD^8*, Caressa Meert, MD^9*, Sergio Ortegon Alcaide, MD^10*, Catherine Thieblemont, MD¹¹, Yajian Jiang, MD, PhD¹², Mina Khoshdeli, PhD^13*, Yanli Wang, MS^13*, Evelyn Guo^13*, Daniela Hoehn, MD, PhD^13* and Sherida Woei-A-Jin, MD, PhD^14*

¹University of Lille, CHU Lille, Lille, France
²4th Department of Internal Medicine – Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic
³Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
⁴MSC National Research Institute of Oncology, Kraków, Poland
⁵Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁶Samsung Medical Center, Seoul, Korea, Republic of (South)
⁷Department of Hematology and Rheumatology, Kindai University, Osaka, Japan
⁸Servicio de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁹Algemeen Ziekenhuis Delta, Roeselare, Belgium
¹⁰Hospital Universitario Virgen Macarena, Sevilla, Spain
¹¹Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France
¹²AbbVie, North Chicago, IL
¹³Genmab, Plainsboro, NJ
¹⁴Department of General Medical Oncology, Universitair Ziekenhuis Leuven, Leuven, Belgium

Sameh Gaballa, MD¹, Jing-Zhou Hou, MD, PhD², Sumana Devata, MD³, Seok-Goo Cho^4*, Ranjit Nair, MD⁵, Dok Hyun Yoon, MD, PhD⁶, Ryan Jacobs, MD⁷, Koji Izutsu, MD, PhD⁸, Don A. Stevens, MD⁹, Dai Maruyama, MD, PhD¹⁰, Constantine S. Tam, MD, MBBS¹¹, Yazeed Sawalha, MD¹², Aravind Ramakrishnan, MD¹³, Matthew Matasar, MD, MS¹⁴, Denise Brennan^15*, Sue Zhu^15*, Robin Lesley, PhD^16*, Yasuhiro Oki, MD¹⁶, David Sermer^17* and Tae Min Kim, MD, PhD^18*

¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Lemieux Center for Blood Cancers, UPMC Hillman Cancer Center, Pittsburgh, PA
³Medical College of Wisconsin, Milwaukee, WI
⁴Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁷Atrium Health Levine Cancer Institute, Charlotte, NC
⁸National Cancer Center Hospital, Tokyo, Japan
⁹Norton Cancer Institute, Norton Health Care, Louisville, KY
¹⁰Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
¹¹Alfred Hospital and Monash University, Melbourne, VIC, Australia
¹²The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹³Sarah Cannon Transplant and Cellular Therapy, St. David’s South Austin Medical Center, Austin, TX
¹⁴Rutgers Cancer Institute, New Brunswick, NJ
¹⁵AstraZeneca, Waltham, MA
¹⁶AstraZeneca, South San Francisco, CA
¹⁷AstraZeneca, New York, NY
¹⁸Seoul National University Hospital, Seoul, Korea, Republic of (South)

Jean-Marie Michot, MD^1*, Franck Morschhauser, phd², Silvia Ferrari, MD^3*, Judit Mészáros Jørgensen, MD, PhD^4*, Loretta Nastoupil^5*, Emmanuel Bachy, MD, PhD⁶, Michael Pourdehnad, MD⁷, Akshay Sudhindra, MD⁸, Alev Akyol, MD^9*, Bérengère de Moucheron, PharmD^10*, Soraya Carrancio, PhD^11*, Jessica Voetsch, PhD^12*, Xirong Zheng, PhD^13* and Julio C. Chavez, MD¹⁴

¹Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France
²University of Lille, Lille, FRA
³ASST Papa Giovanni XXIII, Bergamo, Italy
⁴Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Lyon Sud Hospital, Lyon, France
⁷Early Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, San Francisco, CA
⁸Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Madison, NJ
⁹Bristol Myers Squibb, Princeton, NJ
¹⁰Center for Innovation and Translational Research Europe (CITRE), Bristol Myers Squibb, Seville, Spain
¹¹Oncogenesis (ONC) Thematic Research Center (TRC), Bristol Myers Squibb, San Diego, CA
¹²Translational Informatics and Predictive Sciences, Bristol Myers Squibb, Lawrence Township, NJ
¹³Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb, Princeton, NJ
¹⁴Department of Malignant Hematology, University of South Florida/Moffitt Cancer Center, Tampa, FL

Ariela Noy, MD¹, Stefan K. Barta, MD², Deukwoo Kwon, PhD^3*, Robert Baiocchi, MD, PhD⁴, Juan Carlos Ramos, MD⁵, Paul Rubinstein, MD^6*, Amy Chadburn, MD⁷ and Richard F. Ambinder, MD^8,9

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Abramson Cancer Center, The Fox Chase Cancer Center Foundation, Philadelphia, PA
³Icahn School of Medicine at Mount Sinai, New York, NY
⁴Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁵Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁶Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
⁷Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁸Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
⁹Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD